Spinnaker Investment Group’s AbbVie ABBV Stock Holding History

Spinnaker Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$900K	Buy	3,577 +811	+29%	+$174K	0.14%	61
2026 Q1	$602K	Sell	2,766 -531	-16%	-$118K	0.12%	63
2025 Q4	$753K	Buy	3,297 +24	+0.7%	+$5.47K	0.14%	56
2025 Q3	$758K	Buy	3,273 +773	+31%	+$157K	0.14%	53
2025 Q2	$464K	Sell	2,500 -779	-24%	-$145K	0.11%	55
2025 Q1	$687K	Sell	3,279 -372	-10%	-$72.3K	0.16%	46
2024 Q4	$649K	Sell	3,651 -80	-2%	-$14.7K	0.16%	45
2024 Q3	$737K	Buy	3,731 +167	+5%	+$31.2K	0.18%	40
2024 Q2	$611K	Sell	3,564 -504	-12%	-$83.5K	0.17%	46
2024 Q1	$741K	Buy	4,068 +64	+2%	+$11K	0.21%	38
2023 Q4	$620K	Sell	4,004 -68	-2%	-$9.91K	0.19%	39
2023 Q3	$607K	Buy	4,072 +25	+0.6%	+$3.67K	0.2%	41
2023 Q2	$545K	Buy	4,047 +4	+0.1%	+$587	0.18%	47
2023 Q1	$644K	Buy	4,043 +237	+6%	+$36.2K	0.23%	39
2022 Q4	$615K	Buy	3,806 +182	+5%	+$27.9K	0.22%	39
2022 Q3	$486K	Buy	3,624 +399	+12%	+$57.3K	0.19%	42
2022 Q2	$494K	Buy	3,225 +36	+1%	+$5.5K	0.2%	39
2022 Q1	$518K	Buy	3,189 +297	+10%	+$43.1K	0.17%	49
2021 Q4	$391K	Buy	+2,892	New	+$342K	0.14%	63

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Spinnaker Investment Group's ABBV Position: Q2 2026 in Review

Spinnaker Investment Group increased its AbbVie (ABBV) stake by 29% in Q2 2026, buying an estimated $174K and bringing the position to 3,577 shares worth $900K. The position accounts for 0.14% of the portfolio, ranked #61.

Spinnaker Investment Group first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Spinnaker Investment Group held 3,577 shares of AbbVie worth $900K as of Q2 2026.
Spinnaker Investment Group bought 811 AbbVie shares in Q2 2026, an estimated $174K.
AbbVie made up 0.14% of Spinnaker Investment Group's portfolio in Q2 2026, its #61 holding.
Spinnaker Investment Group first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Spinnaker Investment Group's 13F filing for Q2 2026, filed 10 Jul 2026.